Compedica Holdings Limited

Compedica Holdings Limited is a UK-based medical device technology company specializing in innovative solutions for Diabetic Foot Ulcer (DFU) prevention and treatment. The company develops wearable medical devices and therapeutic products that leverage blood flow enhancement and intermittent plantar compression to address the dual pathophysiology of diabetes: nerve damage and impaired microvascular circulation. Compedica's flagship product, OptiPulse® Active Therapy System, is a prescription-only wearable device that integrates plantar compression therapy with pressure offloading to improve wound healing while maintaining patient mobility and treatment compliance. The company also manufactures specialized diabetic insoles designed for pressure relief and prevention. All products are engineered to foster patient compliance, support local wound care and infection control, and create an oxygen-rich healing environment. Clinical data demonstrates closure of 80% of chronic wounds in compliant patients within 12 weeks. Products are currently in pre-commercial or regulatory evaluation stages across select jurisdictions.